0000950170-24-015944.txt : 20240215 0000950170-24-015944.hdr.sgml : 20240215 20240215163343 ACCESSION NUMBER: 0000950170-24-015944 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TZIANABOS ARTHUR CENTRAL INDEX KEY: 0001586226 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38433 FILM NUMBER: 24644320 MAIL ADDRESS: STREET 1: C/O HOMOLOGY MEDICINES, INC. STREET 2: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Homology Medicines, Inc. CENTRAL INDEX KEY: 0001661998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473468154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-301-7277 MAIL ADDRESS: STREET 1: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 4 1 ownership.xml 4 X0508 4 2024-01-01 0001661998 Homology Medicines, Inc. FIXX 0001586226 TZIANABOS ARTHUR C/O HOMOLOGY MEDICINES, INC. ONE PATRIOTS PARK BEDFORD MA 01730 true false false false true Common Stock 2024-01-01 4 M false 14280 A 122675 D Common Stock 2024-01-01 4 M false 19140 A 141815 D Common Stock 2024-01-09 4 S false 13037 0.5711 D 128778 D Restricted Stock Units 2024-01-01 4 M false 14280 0.00 D Common Stock 14280 0 D Restricted Stock Units 2024-01-01 4 M false 19140 0.00 D Common Stock 19140 19720 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5710 to $0.5712. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. The RSUs are fully vested and do not have an expiration date. The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. /s/ Paul Alloway, Attorney-in-Fact for Arthur O. Tzianabos 2024-02-15